• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Walgreens Sells $1.85B of AmerisourceBergen Shares, Reduces Stake by 16%

Share:

August 8, 2023

Walgreens Boots Alliance has sold AmerisourceBergen shares worth $1.85 billion to reduce debt and for general corporate purposes, with its ownership stake expected to decrease to around 16%.

What You Should Know:

  • Walgreens Boots Alliance announces the sale of shares of AmerisourceBergen Corporation valued at $1.85B for debt paydown and general corporate purposes.
  • Walgreens Boots Alliance’s ownership stake of AmerisourceBergen’s common stock has not been impacted but is expected to decrease by to approximately 16 percent.

Source: HitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • What Therapists Need to Know about Telehealth TechnologyWhat Therapists Need to Know about Telehealth Technology
  • Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining SharesMyovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
  • Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed MergerLeading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
  • UnitedHealth’s Optum has Acquired Vivify Health to Tackle Hospital Readmission RatesUnitedHealth’s Optum has Acquired Vivify Health to Tackle Hospital Readmission Rates
  • Banner Health Deploys Buoy Health AI-Powered Digital Triage ToolBanner Health Deploys Buoy Health AI-Powered Digital Triage Tool
  • Health Catalyst and Amplifire Healthcare Alliance Unite to Boost Measurable Healthcare ImprovementsHealth Catalyst and Amplifire Healthcare Alliance Unite to Boost Measurable Healthcare Improvements
  • Gilead to Buy CymaBay, Lead Liver Disease Asset Seladelpar for $4.3BGilead to Buy CymaBay, Lead Liver Disease Asset Seladelpar for $4.3B
  • Solar Biotech Acquires NoblegenSolar Biotech Acquires Noblegen

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications